LIVE MARKETS-STOXX dragged down by weaker energy, healthcare

By Reuters News

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com



STOXX DRAGGED DOWN BY WEAKER ENERGY, HEALTHCARE

The STOXX 600 .STOXX slipped around 0.2% in early trade on Monday, weighed down by a sharp drop in crude prices that hit energy .SXEP and by weakness in healthcare stocks .SXDP.

Gains in banks .SX7P and a modest rebound in tech .SXP after last week's selloff provided some support, while airlines benefited from lower fuel costs, helping lift the travel and leisure sector .SXTP slightly higher.

The Euro STOXX 50 .STOXX50E blue-chip index fared somewhat better, up 0.1%. In London, the FTSE 100 .FTSE declined 0.2%, with oil major BP BP.L and drugmaker AstraZeneca AZN.L among the biggest drags, both down over 1%.

Alstom ALSO.PA was last down more than 30% after slashing its full-year profitability outlook again.


(Danilo Masoni)


EARLIER ON LIVE MARKETS:

EUROPE BEFORE THE BELL: TECH REBOUNDS, ALSTOM SLUMPS CLICK HERE

MARKETS HOPE FOR RELIEF IN APPLE MARGINS CLICK HERE

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.